IPQ Inside the global regulatory dialogue

Top FDA Drug Compliance Concerns during 2019 Included OTCs, Supply Chain Information Flow, Compounding, and Genotoxic Impurities

Apr 16th, 2020

Please Log in to print the full article

OTC Warning Letters Drive Totals Upward in FY 2017-19 The warning letter totals (not including those involving compounding) doubled during this timeframe – from 43 issued in in FY 2016 to 98 in FY 2019....

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2020 IPQ Publications